J. Goldman & Co LP - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 63 filers reported holding SOLENO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 4.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$231,000
-61.9%
119,873
-50.5%
0.01%
-70.7%
Q3 2020$607,000
-37.6%
241,975
-44.8%
0.04%
-32.8%
Q2 2020$973,000
+189.6%
438,374
+210.6%
0.06%
+52.5%
Q1 2020$336,000
-45.1%
141,140
-32.2%
0.04%
-9.1%
Q4 2019$612,000208,3190.04%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$22,769,0006.37%
CVI Holdings, LLC 1,550,960$3,443,0001.28%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$8,148,0001.03%
Trellus Management Company, LLC 366,432$813,0000.88%
AWM Investment Company, Inc. 1,550,000$3,441,0000.60%
Samsara BioCapital, LLC 750,000$1,665,0000.54%
Nantahala Capital Management 7,426,368$16,487,0000.50%
Consonance Capital Management LP 3,040,000$6,749,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 1,233,676$2,739,0000.26%
Granite Point Capital Management, L.P. 2,200,000$4,884,0000.25%
View complete list of SOLENO THERAPEUTICS INC shareholders